{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:36:32Z","timestamp":1790289392398,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020098","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115974"],"award-info":[{"award-number":["115974"]}],"id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022690","name":"JDRF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022690","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.xkme.2025.101149","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:55:00Z","timestamp":1760554500000},"page":"101149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cardiac Autonomic Neuropathy and Its Impact on Progression of Diabetic Kidney Disease in Type 1 and Type 2 Diabetes"],"prefix":"10.1016","volume":"7","author":[{"given":"Kywe Kywe","family":"Soe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Selvarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xkme.2025.101149_bib1","author":"Centre for Disease Control and Prevention"},{"key":"10.1016\/j.xkme.2025.101149_bib2","series-title":"Oxford Handbook of Nephrology and Hypertension","author":"Steddon","year":"2014"},{"issue":"4","key":"10.1016\/j.xkme.2025.101149_bib3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.pop.2020.08.004","article-title":"Diabetic kidney disease","volume":"47","author":"Bonner","year":"2020","journal-title":"Prim Care"},{"issue":"2","key":"10.1016\/j.xkme.2025.101149_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1464-5491.2008.02496.x","article-title":"Microvascular disease: what does the UKPDS tell us about diabetic nephropathy?","volume":"25","author":"Bilous","year":"2008","journal-title":"Diabet Med"},{"issue":"1-2","key":"10.1016\/j.xkme.2025.101149_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1900\/RDS.2015.12.87","article-title":"Diabetic kidney disease: a syndrome rather than a single disease","volume":"12","author":"Piccoli","year":"2015","journal-title":"Rev Diabet Stud"},{"issue":"9","key":"10.1016\/j.xkme.2025.101149_bib6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.mpmed.2019.06.010","article-title":"Epidemiology and causes of chronic kidney disease","volume":"47","author":"Noble","year":"2019","journal-title":"Medicine"},{"issue":"Suppl 1","key":"10.1016\/j.xkme.2025.101149_bib7","first-page":"S151","article-title":"11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"issue":"4S","key":"10.1016\/j.xkme.2025.101149_bib8","first-page":"S1","article-title":"KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease","volume":"98","year":"2020","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.xkme.2025.101149_bib9","first-page":"751","article-title":"Diabetic kidney disease: diagnosis, treatment, and prevention","volume":"99","author":"McGrath","year":"2019","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.xkme.2025.101149_bib10","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","author":"Eknoyan","year":"2022","journal-title":"KDIGO Guidelines"},{"issue":"3","key":"10.1016\/j.xkme.2025.101149_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4997\/jrcpe.2020.310","article-title":"Diabetic autonomic neuropathy: a clinical update","volume":"50","author":"Sharma","year":"2020","journal-title":"J R Coll Physicians Edinb"},{"issue":"7","key":"10.1016\/j.xkme.2025.101149_bib12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/dmrr.1239","article-title":"Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management","volume":"27","author":"Spallone","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.xkme.2025.101149_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2147\/DMSO.S129797","article-title":"Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives","volume":"10","author":"Fisher","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"12","key":"10.1016\/j.xkme.2025.101149_bib14","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.jacc.2004.09.033","article-title":"Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction","volume":"44","author":"Pop-Busui","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.xkme.2025.101149_bib15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1464-5491.2004.01145.x","article-title":"Left ventricular dysfunction in normotensive type 1 diabetic patients: the impact of autonomic neuropathy","volume":"21","author":"Taskiran","year":"2004","journal-title":"Diabet Med"},{"issue":"7","key":"10.1016\/j.xkme.2025.101149_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrendo.2012.21","article-title":"Cardiovascular autonomic neuropathies as complications of diabetes mellitus","volume":"8","author":"Kuehl","year":"2012","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"10.1016\/j.xkme.2025.101149_bib17","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.clinthera.2022.09.002","article-title":"Cardiac autonomic neuropathy in type 1 and 2 diabetes: epidemiology, pathophysiology, and management","volume":"44","author":"Williams","year":"2022","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.xkme.2025.101149_bib18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00000542-198904000-00006","article-title":"Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy","volume":"70","author":"Burgos","year":"1989","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.xkme.2025.101149_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11428-020-00596-w","article-title":"Autonome diabetische Neuropathie","volume":"16","author":"Ziegler","year":"2020","journal-title":"Der Diabetologe"},{"issue":"3","key":"10.1016\/j.xkme.2025.101149_bib20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/BF00418273","article-title":"Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients","volume":"34","author":"Ewing","year":"1991","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.xkme.2025.101149_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4093\/dmj.2018.0259","article-title":"Update on the impact, diagnosis and management of cardiovascular autonomic neuropathy in diabetes: what is defined, what is new, and what is unmet","volume":"43","author":"Spallone","year":"2019","journal-title":"Diabetes Metab J"},{"issue":"Suppl 1","key":"10.1016\/j.xkme.2025.101149_bib22","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2009.24.S1.S69","article-title":"Cardiac autonomic neuropathy as a predictor of deterioration of the renal function in normoalbuminuric, normotensive patients with type 2 diabetes mellitus","volume":"24","author":"Kim","year":"2009","journal-title":"J Korean Med Sci"},{"issue":"4","key":"10.1016\/j.xkme.2025.101149_bib23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/hrt.55.4.348","article-title":"Heart rate variability in healthy subjects: Effect of age and the derivation of normal ranges for tests of autonomic function","volume":"55","author":"O\u2019Brien","year":"1986","journal-title":"Br Heart J"},{"issue":"5","key":"10.1016\/j.xkme.2025.101149_bib24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diacare.8.5.491","article-title":"The value of cardiovascular autonomic function tests: 10 years experience in diabetes","volume":"8","author":"Ewing","year":"1985","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xkme.2025.101149_bib25","series-title":"Reflex Control of the Circulation","article-title":"Neural control of renal function\u2217","author":"Kopp","year":"2020"},{"issue":"1","key":"10.1016\/j.xkme.2025.101149_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.diabres.2015.01.031","article-title":"The association between abnormal heart rate variability and new onset of chronic kidney disease in patients with type 2 diabetes: a ten-year follow-up study","volume":"108","author":"Yun","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.xkme.2025.101149_bib27","article-title":"Supply of Blood and Nerves to the Kidneys","year":"2020","journal-title":"MedLibretexts.org"},{"issue":"3","key":"10.1016\/j.xkme.2025.101149_bib28","doi-asserted-by":"crossref","first-page":"R633","DOI":"10.1152\/ajpregu.00258.2005","article-title":"Physiology in perspective: the wisdom of the body. Neural control of the kidney","volume":"289","author":"DiBona","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"5","key":"10.1016\/j.xkme.2025.101149_bib29","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/diacare.16.5.773","article-title":"Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM","volume":"16","author":"Sundkvist","year":"1993","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.xkme.2025.101149_bib30","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2337\/diacare.17.6.578","article-title":"Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients","volume":"17","author":"Spallone","year":"1994","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.xkme.2025.101149_bib31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1530\/eje.0.1350683","article-title":"Altered blood pressure profile, autonomic neuropathy and nephropathy in insulin-dependent diabetic patients","volume":"135","author":"Monteagudo","year":"1996","journal-title":"Eur J Endocrinol"},{"issue":"3 I","key":"10.1016\/j.xkme.2025.101149_bib32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0895-7061(97)00472-X","article-title":"Relationship between autonomic function and progression of renal disease in diabetic proteinuria: Clinical correlations and implications for blood pressure control","volume":"11","author":"Weinrauch","year":"1998","journal-title":"Am J Hypertens"},{"issue":"5","key":"10.1016\/j.xkme.2025.101149_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF02277970","article-title":"Autonomic neuropathy in asymptomatic subjects with non-insulin-dependent diabetes mellitus and microalbuminuria","volume":"8","author":"Rutter","year":"1998","journal-title":"Clin Auton Res"},{"issue":"9","key":"10.1016\/j.xkme.2025.101149_bib34","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2337\/diacare.23.9.1369","article-title":"Cardiovascular autonomic function is associated with (micro-)albuminuria in elderly Caucasian subjects with impaired glucose tolerance or type 2 diabetes: the Hoorn Study","volume":"23","author":"Smulders","year":"2000","journal-title":"Diabetes Care"},{"issue":"2-3","key":"10.1016\/j.xkme.2025.101149_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0167-5273(02)00346-7","article-title":"Marked abnormalities in heart rate variability are associated with progressive deterioration of renal function in type I diabetic patients with overt nephropathy","volume":"86","author":"Burger","year":"2002","journal-title":"Int J Cardiol"},{"issue":"8","key":"10.1016\/j.xkme.2025.101149_bib36","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1464-5491.2004.01255.x","article-title":"A 14-year prospective study of autonomic nerve function in Type 1 diabetic patients: association with nephropathy","volume":"21","author":"Fors\u00e9n","year":"2004","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.xkme.2025.101149_bib37","doi-asserted-by":"crossref","first-page":"972","DOI":"10.2337\/diacare.27.4.972","article-title":"Cardiovascular autonomic neuropathy is associated with microalbuminuria in older patients with type 2 diabetes","volume":"27","author":"Moran","year":"2004","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.xkme.2025.101149_bib38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00000441-200602000-00012","article-title":"Relationships between heart rate variability and urinary albumin excretion in patients with type 2 diabetes","volume":"331","author":"Takebayashi","year":"2006","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.xkme.2025.101149_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/dc06-0793","article-title":"Autonomic nerve testing predicts the development of complications: A 12-year follow-up study","volume":"30","author":"Maguire","year":"2007","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.xkme.2025.101149_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jdiacomp.2006.12.003","article-title":"Increasing severity of cardiac autonomic neuropathy is associated with increasing prevalence of nephropathy, retinopathy, and peripheral neuropathy in Turkish type 2 diabetics","volume":"22","author":"Bilal","year":"2008","journal-title":"J Diabetes Complications"},{"issue":"6","key":"10.1016\/j.xkme.2025.101149_bib41","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00125-014-3211-2","article-title":"Cardiac autonomic neuropathy predicts renal function decline in patients with type 2 diabetes: a cohort study","volume":"57","author":"Tahrani","year":"2014","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.xkme.2025.101149_bib42","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2215\/CJN.11441114","article-title":"Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes","volume":"10","author":"Orlov","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2025.101149_bib43","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jdiacomp.2016.03.008","article-title":"Cardiovascular autonomic neuropathy associates with nephropathy lesions in American Indians with type 2 diabetes","volume":"30","author":"Wheelock","year":"2016","journal-title":"J Diabetes Complications"},{"issue":"14","key":"10.1016\/j.xkme.2025.101149_bib44","doi-asserted-by":"crossref","first-page":"800","DOI":"10.18410\/jebmh\/2017\/154","article-title":"Cardiac autonomic neuropathy and microalbuminuria in type 2 diabetes mellitus: a cross-sectional analysis","volume":"4","author":"Padmini","year":"2017","journal-title":"J Evid Based Med Healthc"},{"issue":"1","key":"10.1016\/j.xkme.2025.101149_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002289","article-title":"Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes","volume":"9","author":"Bjerre-Christensen","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.xkme.2025.101149_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.780679","article-title":"The association between cardiovascular autonomic function and changes in kidney and myocardial function in type 2 diabetes and healthy controls","volume":"12","author":"Laursen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.xkme.2025.101149_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98505-8","article-title":"Sleep quality, autonomic dysfunction and renal function in diabetic patients with pre-CKD phase","volume":"11","author":"Kadoya","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.xkme.2025.101149_bib48","first-page":"3","article-title":"Correlations of cardiovascular autonomic neuropathy with urinary albumin excretion rate and cardiac function in patients with type 2 diabetes mellitus","volume":"49","author":"Chen","year":"2024","journal-title":"Minerva Endocrinol (Torino)"},{"key":"10.1016\/j.xkme.2025.101149_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109181","article-title":"Cardiovascular autonomic neuropathy and incident diabetic kidney disease in patients with type 2 diabetes","volume":"184","author":"Eun Jun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.xkme.2025.101149_bib50","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/jdi.13625","article-title":"Decline in renal function associated with cardiovascular autonomic neuropathy positively coordinated with proteinuria in patients with type 2 diabetes","volume":"13","author":"Muramatsu","year":"2022","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.xkme.2025.101149_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.900465","article-title":"Cardiac autonomic dysfunction is associated with risk of diabetic kidney disease progression in type 2 diabetes mellitus","volume":"13","author":"Zeng","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"10.1016\/j.xkme.2025.101149_bib52","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2337\/db23-0247","article-title":"Cardiovascular autonomic neuropathy and risk of kidney function decline in type 1 and type 2 diabetes: findings from the PERL and ACCORD cohorts","volume":"73","author":"Tang","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.xkme.2025.101149_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1462610","article-title":"Cardiovascular autonomic neuropathy and the risk of diabetic kidney disease","volume":"15","author":"Cho","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.xkme.2025.101149_bib54","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12882-024-03879-2","article-title":"Cardiovascular autonomic neuropathy in chronic kidney disease: a study of kidney biopsy cases","volume":"25","author":"Kuno","year":"2024","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101149_bib55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4239\/wjd.v5.i1.17","article-title":"Cardiac autonomic neuropathy in patients with diabetes mellitus","volume":"5","author":"Dimitropoulos","year":"2014","journal-title":"World J Diabetes"},{"issue":"5","key":"10.1016\/j.xkme.2025.101149_bib56","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1464-5491.1986.tb00786.x","article-title":"The relationship between autonomic neuropathy and urinary sodium and albumin excretion in insulin-treated diabetics","volume":"3","author":"Winocour","year":"1986","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.xkme.2025.101149_bib57","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12265-012-9367-6","article-title":"What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes","volume":"5","author":"Pop-Busui","year":"2012","journal-title":"J Cardiovasc Transl Res"},{"issue":"5","key":"10.1016\/j.xkme.2025.101149_bib58","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/13510002.2016.1173326","article-title":"Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease","volume":"22","author":"Fadaee","year":"2017","journal-title":"Redox Rep"},{"issue":"5","key":"10.1016\/j.xkme.2025.101149_bib59","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3390\/ijms21051647","article-title":"Renal sympathetic nerve-derived signaling in acute and chronic kidney diseases","volume":"21","author":"Noh","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.xkme.2025.101149_bib60","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.2337\/diab.39.12.1556","article-title":"Recognition of hypertension and abnormal blood pressure burden with ambulatory blood pressure recordings in type I diabetes mellitus","volume":"39","author":"Wiegmann","year":"1990","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.xkme.2025.101149_bib61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.jhh.1001170","article-title":"Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes","volume":"15","author":"Spallone","year":"2001","journal-title":"J Hum Hypertens"},{"issue":"10","key":"10.1016\/j.xkme.2025.101149_bib62","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/hr.2010.130","article-title":"Autonomic nervous system activity is independently associated with the risk of shift in the non-dipper blood pressure pattern","volume":"33","author":"Dauphinot","year":"2010","journal-title":"Hypertens Res"},{"issue":"11","key":"10.1016\/j.xkme.2025.101149_bib63","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1111\/dom.14798","article-title":"Prognostic value of 24-hour ambulatory blood pressure patterns in diabetes: A 21-year longitudinal study","volume":"24","author":"Chiriac\u00f2","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"10.1016\/j.xkme.2025.101149_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2022.108320","article-title":"Renal hemodynamic dysfunction and neuropathy in longstanding type 1 diabetes: Results from the Canadian study of longevity in type 1 diabetes","volume":"36","author":"Lytvyn","year":"2022","journal-title":"J Diabetes Complications"},{"issue":"5","key":"10.1016\/j.xkme.2025.101149_bib65","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41591-019-0415-5","article-title":"A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes","volume":"25","author":"Niewczas","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.xkme.2025.101149_bib66","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: A position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.xkme.2025.101149_bib67","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00415-016-8375-x","article-title":"The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension","volume":"264","author":"Gibbons","year":"2017","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101149_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdiacomp.2005.05.002","article-title":"Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy","volume":"20","author":"Didangelos","year":"2006","journal-title":"J Diabetes Complications"},{"issue":"3","key":"10.1016\/j.xkme.2025.101149_bib69","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2337\/diacare.20.3.355","article-title":"Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy","volume":"20","author":"Kontopoulos","year":"1997","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.xkme.2025.101149_bib70","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012307","article-title":"Nocturnal antihypertensive treatment in patients with type 1 diabetes with autonomic neuropathy and non-dipping: A randomised, placebo-controlled, double-blind cross-over trial","volume":"6","author":"Hjortkjaer","year":"2016","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.xkme.2025.101149_bib71","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00125-002-0869-7","article-title":"Effects on heart rate variability of metoprolol supplementary to ongoing ACE-inhibitor treatment in type I diabetic patients with abnormal albuminuria","volume":"45","author":"Ebbeh\u00f8j","year":"2002","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.xkme.2025.101149_bib72","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/ajcn\/73.6.1052","article-title":"Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes","volume":"73","author":"Manzella","year":"2001","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.xkme.2025.101149_bib73","doi-asserted-by":"crossref","first-page":"62","DOI":"10.14341\/DM9630","article-title":"The effect of omega-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy","volume":"22","author":"Serhiyenko","year":"2019","journal-title":"Diabetes Mellitus"},{"issue":"5","key":"10.1016\/j.xkme.2025.101149_bib74","doi-asserted-by":"crossref","first-page":"56","DOI":"10.15829\/1560-4071-2018-5-56-60","article-title":"Effects of omega-3 polyunsaturated fatty acids on the circadian rhythm of heart rate variability parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy","author":"Serhiyenko","year":"2018","journal-title":"Russ J Cardiol"},{"key":"10.1016\/j.xkme.2025.101149_bib75","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.metabol.2018.07.002","article-title":"The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials","volume":"87","author":"Akbari","year":"2018","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.xkme.2025.101149_bib76","first-page":"457","article-title":"Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study)","volume":"42","author":"Tankova","year":"2004","journal-title":"Rom J Intern Med"},{"issue":"11","key":"10.1016\/j.xkme.2025.101149_bib77","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.3390\/nu12113254","article-title":"Efficacy and safety of the combination of superoxide dismutase, alpha lipoic acid, vitamin B12, and carnitine for 12 months in patients with diabetic neuropathy","volume":"12","author":"Didangelos","year":"2020","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.xkme.2025.101149_bib78","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a034173","article-title":"Vagus nerve stimulation and the cardiovascular system","volume":"10","author":"Capilupi","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"10.1016\/j.xkme.2025.101149_bib79","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.seizure.2012.12.011","article-title":"Case report: Vagal nerve stimulation and late onset asystole","volume":"22","author":"Shankar","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.xkme.2025.101149_bib80","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.seizure.2015.01.006","article-title":"Vagus nerve stimulation and late-onset bradycardia and asystole: case report","volume":"26","author":"Pascual","year":"2015","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.xkme.2025.101149_bib81","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00004691-200109000-00005","article-title":"Vagus nerve stimulation, side effects, and long-term safety","volume":"18","author":"Ben-Menachem","year":"2001","journal-title":"J Clin Neurophysiol"},{"issue":"24","key":"10.1016\/j.xkme.2025.101149_bib82","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.xkme.2025.101149_bib83","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.xkme.2025.101149_bib84","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"The EMPA-KIDNEY Collaborative Group","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.xkme.2025.101149_bib85","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.xkme.2025.101149_bib86","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/eurheartj\/ehaa736","article-title":"Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine","volume":"42","author":"Agarwal","year":"2021","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.xkme.2025.101149_bib87","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.xkme.2025.101149_bib88","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.xkme.2025.101149_bib89","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2215\/CJN.06870520","article-title":"Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN): Phase 3 Randomized Controlled Clinical Trial","volume":"15","author":"Ito","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.xkme.2025.101149_bib90","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2215\/CJN.14751218","article-title":"Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial","volume":"14","author":"Ito","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101149_bib91","article-title":"The natural history of diabetic autonomic neuropathy","volume":"49","author":"Ewing","year":"1980","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.xkme.2025.101149_bib92","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF02322053","article-title":"Standardized tests of heart rate variability: Normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate","volume":"11","author":"Agelink","year":"2001","journal-title":"Clin Auton Res"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525001852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525001852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:06:00Z","timestamp":1773813960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059525001852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":92,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2590059525001852"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101149","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Autonomic Neuropathy and Its Impact on Progression of Diabetic Kidney Disease in Type 1 and Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101149"}}